ARS Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ARS Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2025.
  • ARS Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $1.44M, a 1464% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

ARS Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.44M +$1.35M +1464% Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $1.56M +$1.42M +971% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $72K -$126K -63.6% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $37K -$213K -85.2% Dec 31, 2024 10-Q 2025-11-10
Q3 2024 $92K -$208K -69.3% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $146K -$203K -58.2% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $198K -$200K -50.3% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $250K -$195K -43.8% Dec 31, 2023 10-K 2025-03-20
Q3 2023 $300K +$300K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $349K -$3.57M -91.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $398K -$4.09M -91.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $445K -$176K -28.3% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $0 -$5.01M -100% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $3.92M +$2.3M +143% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $4.48M +$2.58M +136% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $621K -$1.56M -71.5% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $5.01M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.62M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.9M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $2.18M Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.